NYSE : DOCS
Doximity, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 33.63 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.99B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.84B |
| Enterprise Value | 5.16B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 127.35M |
| Shares Outstanding | 178.25M |
| Shares Change (YoY) | -2.55% |
| Shares Change (QoQ) | -1.98% |
| Owned by Insiders (%) | 28.87% |
| Owned by Institutions (%) | 74.64% |
| Float | 123.63M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 38.88 |
| Forward PE | 22.98 |
| PS Ratio | 8.91 |
| Forward PS | 8.54 |
| PB Ratio | 6.43 |
| P/TBV Ratio | 7.32 |
| P/FCF Ratio | 19.07 |
| P/OCF Ratio | 19.06 |
| PEG Ratio | 13.33 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 30.90 |
| EV / Sales | 7.87 |
| EV / EBITDA | 24.77 |
| EV / EBIT | 25.75 |
| EV / FCF | 16.85 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 6.08 |
| Quick Ratio | 5.80 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 17.21% |
| Return on Assets (ROA) | 10.95% |
| Return on Invested Capital (ROIC) | 65.72% |
| Return on Capital Employed (ROCE) | 21.47% |
| Weighted Average Cost of Capital (WACC) | 11.33% |
| Revenue Per Employee | $744,964 |
| Profits Per Employee | $189,825 |
| Employee Count | 880 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 59.18M |
| Effective Tax Rate | 26.16% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -50.94% |
| 50-Day Moving Average | 28.29 |
| 200-Day Moving Average | 25.55 |
| Relative Strength Index (RSI) | 61.67 |
| Average Volume (20 Days) | 2,900,582 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.08M |
| Short Previous Month | 12.38M |
| Short % of Shares Out | 5.10% |
| Short % of Float | 7.35% |
| Short Ratio (days to cover) | 2.84 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 655.57M |
| Gross Profit | 577.34M |
| Operating Income | 200.43M |
| Pretax Income | 226.22M |
| Net Income | 167.05M |
| EBITDA | 208.40M |
| EBIT | 200.43M |
| Earnings Per Share (EPS) | $0.84 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 687.79M |
| Total Debt | 9.67M |
| Net Cash | 678.12M |
| Net Cash Per Share | $3.80 |
| Equity (Book Value) | 916.07M |
| Book Value Per Share | 5.09 |
| Working Capital | 763.62M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 306.34M |
| Capital Expenditures | -62,000 |
| Depreciation & Amortization | 7.98M |
| Net Borrowing | n/a |
| Free Cash Flow | 306.28M |
| FCF Per Share | $1.72 |
Margins
| Measure | Value |
|---|
| Gross Margin | 88.07% |
| Operating Margin | 30.57% |
| Pretax Margin | 34.51% |
| Profit Margin | 25.48% |
| EBITDA Margin | 31.79% |
| EBIT Margin | 30.57% |
| FCF Margin | 46.72% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.55% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.57% |
| FCF Yield | 5.25% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $31.11 |
| Price Target Difference | -5.04% |
| Analyst Consensus | Hold |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | 6.73% |
| EPS Growth Forecast (3Y) | 6.17% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 31.3 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |